COCRYSTAL PHARMA, INC. Deferred Tax Assets, Other Loss Carryforwards
COCRYSTAL PHARMA, INC. (COCP) had Deferred Tax Assets, Other Loss Carryforwards of $311.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-17.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherLossCarryforwards · last filed 2021-03-17
- 2020-12-31: Deferred Tax Assets, Other Loss Carryforwards $311.00K.
- 2019-12-31: Deferred Tax Assets, Other Loss Carryforwards $121.00K.
- 2018-12-31: Deferred Tax Assets, Other Loss Carryforwards $84.00K.
- 2017-12-31: Deferred Tax Assets, Other Loss Carryforwards $373.00K.
| Period end | Deferred Tax Assets, Other Loss Carryforwards |
|---|---|
| 2020-12-31 | $311.00K 10-K · filed 2021-03-17 |
| 2019-12-31 | $121.00K 10-K · filed 2021-03-17 |
| 2018-12-31 | $84.00K 10-K · filed 2020-03-27 |
| 2017-12-31 | $373.00K 10-K · filed 2019-04-01 |
| 2016-12-31 | $545.00K 10-K · filed 2018-03-21 |
| 2015-12-31 | $128.00K 10-K · filed 2017-03-31 |
| 2014-12-31 | $65.00K 10-K · filed 2016-03-15 |
| 2013-12-31 | $1.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |